A study published today by the journal ACS Chemical Neuroscience by researchers from North Dakota State University found that an early intervention using cannabidiol (CBD) alongside brain-derived neurotrophic factor (BDNF) delivered through targeted nanoparticles reduced key markers tied to Alzheimer’s disease while also improving cognitive function. The study focused on a commonly used animal model …
Category: CBD Studies
Peer-reviewed studies focused on the compound cannabidiol (CBD), which is a nonpsychoactive component of the cannabis plant.
CBD May Help Ease Pain and Improve Recovery After Exercise-Related Muscle Injury, Study Finds
A new study published in Journal of Cannabis Research and listed by the U.S. National Library of Medicine found that cannabidiol (CBD) may help reduce pain and physical limitations tied to exercise-related muscle injury, while also appearing to be safe and well tolerated. Researchers from Augusta University and the University of Florida conducted the study …
Cannabidiol Shows Potential to Support Weight Gain and Symptom Improvement in Anorexia, Study Finds
A clinical trial published in the International Journal of Eating Disorders finds that cannabidiol (CBD) may support weight restoration and improve certain symptoms in individuals with anorexia nervosa, while being well tolerated with minimal side effects. Researchers from the University of Southern California and the University of California San Diego conducted a randomized, double-blind, placebo-controlled …
CBD Nanoemulsion Using Argan Oil Shows Promise for Psoriasis Treatment
According to a study published by the journal Pharmaceutics, CBD formulated in a nanoemulsion with argan oil may offer an effective topical approach for treating psoriasis, with improved stability and controlled drug delivery compared to conventional formulations. The study was conducted by researchers from the University of Texas Rio Grande Valley, Abdelmalek Essaâdi University, and the …
Study: CBD Found to Disrupt Key Infection Mechanisms of Listeria
A new study published in the International Journal of Molecular Sciences found that cannabidiol (CBD) may significantly reduce the ability of Listeria monocytogenes to infect and damage host cells, pointing to potential applications in both food safety and treatment strategies. The study, conducted by researchers from the University of Connecticut, University of Florida and the …
CBD and Sodium Propionate Enema Reduced Colitis Severity in New Study
A recent study published in Journal of Cannabis Research found that a rectal enema combining cannabidiol (CBD) and sodium propionate reduced disease severity in mice with ulcerative colitis, performing better than either treatment used on its own. Researchers from Tel Aviv University examined the experimental treatment in a murine model of dextran sodium sulfate-induced colitis, …
Survey: Vast Majority of Veterinarians in Portugal Report Using CBD for Pets, High Satisfaction Across Multiple Conditions
A survey published in the Journal of Animal Physiology and Animal Nutrition by researchers from the University of Trás-os-Montes and Alto Douro finds that CBD is widely used among small animal veterinarians in Portugal, particularly for dogs and cats, with many reporting positive outcomes across a range of conditions.
Study Finds Powder-Based CBD Formulation Dramatically Improves Stability Over Oil
According to a study being published in the August issue of the Journal of Pharmaceutical and Biomedical Analysis, and published online ahead of print by the U.S. National Library of Medicine, how cannabidiol (CBD) is formulated plays a major role in how well it holds up over time, with powder-based systems significantly outperforming traditional oil …
Study: CBD Reduces Seizure Frequency in Patients With Rare Epilepsy Syndromes
A new multicenter study has found that highly purified cannabidiol (CBD) significantly reduces seizure frequency in patients with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), and tuberous sclerosis complex (TSC)-associated epilepsy. Researchers in Germany conducted a retrospective review of medical records from 202 patients who received at least one dose of Epidyolex, a 100 mg/mL oral …
Study: CBD Inhibits Osteosarcoma by Targeting Tumor-Driving Inflammation
A new study published in Phytomedicine finds that cannabidiol (CBD) can significantly inhibit the growth and spread of osteosarcoma, a highly aggressive bone cancer, by targeting a key inflammatory pathway. “Osteosarcoma remains a therapeutic challenge due to its aggressive behavior and high metastatic potential, necessitating exploration of novel treatment modalities”, states the study’s abstract. “Cannabidiol …
